CapLaw-2020-60

  • ADC Therapeutics SA’s Follow-on Offering on the New York Stock Exchange

    On 23 September 2020, ADC Therapeutics SA (NYSE: ADCT), a Swiss-based late clinicalstage oncology-focused biotechnology company pioneering the development and commercialization of antibody drug conjugates, announced the pricing of its upsized follow-on public offering of shares in the United States, thus raising gross proceeds of approx. USD 204m. In addition, certain existing shareholders had granted…

    By

    CapLaw

    Reference:
    Read more: ADC Therapeutics SA’s Follow-on Offering on the New York Stock Exchange